Premium
P3–444: Proteasomal inhibition increases alpha–synuclein levels in an amyloid–beta–dependent manner
Author(s) -
Frasier Mark,
DeLong Cynthia,
Bales Kelly,
Merchant Kalpana M.
Publication year - 2006
Publication title -
alzheimer's and dementia
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2006.05.1715
Subject(s) - alpha synuclein , genetically modified mouse , parkinson's disease , amyloid (mycology) , transgene , extracellular , in vivo , biology , proteasome , disease , microbiology and biotechnology , neuroscience , chemistry , medicine , pathology , biochemistry , genetics , gene